BioReference Laboratories is the largest full service specialty laboratory in the United States that gives healthcare providers and patients the information to make confident healthcare decisions. With a focus on genetics, oncology, urology and women’s health, BioReference offers comprehensive test solutions and unparalleled expertise based on a 40 year legacy of proven science. The company is in-network with the largest health plans in the United States, serves approximately 19 million patients annually, operates a network of 10 laboratory locations, and is backed by a medical staff of more than 300 M.D., D.O., Ph.D., genetic counselors and other professional clinical and scientific personnel. With a national footprint and niche market experience, BioReference provides credible and innovative solutions that meet the needs of employers, governmental agencies, educational systems, hospitals and health systems, correctional institutions, sports leagues, travel and leisure industries, and retail markets. BioReference provides industry-leading custom solutions for COVID-19, including point-of-care testing and large-scale screening programs. The COVID-19 pandemic has significantly changed how healthcare providers and patients view healthcare, and telemedicine has grown at an unprecedented rate. These changes will continue to transform healthcare and diagnostics now and in the future. As a physician-founded and physician-led laboratory, BioReference has always challenged the industry with a patient-centric approach. Now, as the healthcare industry moves into the next era, BioReference is prepared to meet the evolving needs of healthcare providers and consumers with solutions that are proven, agile, collaborative, patient-centric and digitally enabled.